SummaryRMgm-5001
|
Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) | Gene tagging |
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 33791240 |
MR4 number | |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. berghei |
Parent strain/line | P. berghei ANKA |
Name parent line/clone | P. berghei ANKA 2.34 |
Other information parent line | P. berghei ANKA 2.34 is a cloned, gametocyte producer line of the ANKA strain (PubMed: PMID: 15137943). |
top of page | |
The mutant parasite was generated by | |
Name PI/Researcher | Ukegbu CV, Vlachou D |
Name Group/Department | Department of Life Sciences |
Name Institute | Imperial College London |
City | London |
Country | UK |
top of page | |
Name of the mutant parasite | |
RMgm number | RMgm-5001 |
Principal name | c57::gfp |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | Yes |
top of page | |
Phenotype | |
Asexual blood stage | Not different from wild type |
Gametocyte/Gamete | Not different from wild type |
Fertilization and ookinete | See additional information below |
Oocyst | Severely reduced sporozoite numbers, suggesting that insertion of GFP compromises the function of the protein. |
Sporozoite | Severely reduced sporozoite numbers, suggesting that insertion of GFP compromises the function of the protein. |
Liver stage | Not tested |
Additional remarks phenotype | Mutant/mutation Protein (function) Phenotype PbPIMMS01 and PbPIMMS57 transcripts were highly abundant in purified mature ookinetes and not detectable in mixed blood stages and purified gametocytes. While PbPIMMS57 appears to be specific for ookinetes, low levels of PbPIMMS01 transcripts are also detected in mature oocysts and midgut sporozoites at 10 days and 15 days post blood-feeding. Like PfPIMMS22, expression of PbPIMMS22 starts in gametocytes and continues at high levels at 24 hour and peaks in midgut sporozoites at day 15. From the abstract:
|
top of page | |||||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||||
Gene Model of Rodent Parasite | PBANKA_1457700 | ||||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_1244500 | ||||||||||||||||||||||||||
Gene product | PIMMS57 protein | ||||||||||||||||||||||||||
Gene product: Alternative name | PIMMS57 | ||||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||||
Name of the tag | GFP | ||||||||||||||||||||||||||
Details of tagging | C-terminal | ||||||||||||||||||||||||||
Additional remarks: tagging | |||||||||||||||||||||||||||
Commercial source of tag-antibodies | |||||||||||||||||||||||||||
Type of plasmid/construct | (Linear) plasmid double cross-over | ||||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||||
Restriction sites to linearize plasmid | |||||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | tgdhfr | ||||||||||||||||||||||||||
Promoter of the selectable marker | pbdhfr | ||||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||||
Additional remarks genetic modification | For GFP tagging of Pbc01 in the 2.34 line, a 603 bp ApaI/HindIII 5’ and a 770 bp EcoRI/BamHI 3’ homology arm region were amplified from P. berghei 2.34 genomic DNA using the primer pairs P1/P2 and P3/P4, respectively. For GFP tagging of Pbc57 in the 2.34 line, a 919 bp ApaI/SacII 5’ homology arm corresponding to the most 3’ region of the CDS without the stop codon and a 359 bp XhoI/XmaI 3’ homology arm region corresponding to the 3’ UTR of the gene were amplified using the primer pairs P5/P6 and P7/P8, respectively. For GFP tagging of Pbc22 in the 2.34 line, a 753 bp ApaI/HindIII 5’ homology arm corresponding to the most 3’ region of the CDS without the stop codon and a 530 bp EcoRI/BamHI 3’ homology arm region corresponding to the 3’ UTR of the gene were amplified using the primer pairs P9/P10 and P11/P12, respectively. The Pbc01 and Pbc22 fragments were cloned into the pBS-TgDHFR vector which carries a modified Toxoplasma gondii dihydrofolate gene (TgDHFR/TS) cassette that confers resistance to pyrimethamine (Dessens et al., 1999). The Pbc57 fragments were cloned into plasmid pL0035 which carries the hDHFR selection cassette. Finally, to put GFP tag in frame with the 3’ region of the CDS, a HindIII or SacII GFP- P. berghei DHFR 3’UTR fragment was amplified from the pL00018 vector (MRA787, MR4) using primers P13/P14 or P15/P16, respectively. | ||||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
top of page |